SESH FRAGRANCE ACADEMY | ADVANCED SAFETY & COMPLIANCE
Why can the same perfume label need different legal treatment across markets?
The exclamation mark is a GHS hazard pictogram example. Its interpretation and a material’s actual classification come from its safety data sheet; this is a teaching example.
Open full-size image ↗Build market-specific label review checklists and distinguish ingredient disclosure, claims, premarket duties and supporting technical dossiers.
1. Start with destination and product classification
A label prepared for Egypt, the United States or the European Union cannot automatically be reused unchanged in every market. Start with jurisdiction, product classification, intended use, the manufacturer/importer or legally responsible entity and sales channel. Label content and supporting obligations depend on local law. Translating a single English label is not a substitute for jurisdiction-specific compliance review.
2. EU cosmetics require a responsible compliance chain
EU Regulation (EC) 1223/2009 establishes a wider cosmetics framework: an EU Responsible Person, ingredient listing under relevant nomenclature, nominal content as applicable, batch traceability, required warnings and other label particulars, plus an appropriate Cosmetic Product Safety Report, Product Information File and CPNP notification before placing the product on the market. An INCI list by itself is not evidence that those obligations were met.
The flame is an example used to recognise flammability hazards. Its use here does not classify a particular product; consult the material-specific documentation.
Open full-size image ↗3. EU fragrance-allergen transition: a specific 2026 check
Regulation (EU) 2023/1545 expanded required individual fragrance-allergen declarations, subject to specified naming, grouped entries and thresholds. As of October 2026 the 31 July 2026 deadline for placing non-compliant products on the EU market has passed; certain pre-existing stock can remain available until 31 July 2028 under transitional provisions. Do not mistake the later sell-through date for permission to newly place noncompliant products. Check the official legal text and subsequent amendments.
4. The U.S. has its own rules and exemptions
The FDA generally treats perfumes intended for application to the body as cosmetics. Under certain U.S. labeling provisions, fragrance blends may be declared as 'fragrance' without revealing a proprietary formula; this is not identical to EU allergen disclosure. MoCRA introduces applicable facility registration, product listing, safety substantiation and adverse-event responsibilities, with defined exemptions. Facility registration or product listing is not an FDA endorsement or blanket premarket approval of individual cosmetic claims.
5. Egypt requires its own current regulatory review
For sale in Egypt, the responsible team must verify current national cosmetic-product procedures and label, language, responsible-party, distribution and filing requirements with the competent authority and up-to-date official sources. U.S. and EU templates are not automatically compliant in Egypt. Keep a separate country checklist and obtain current official confirmation rather than relying on unverified numeric rules or outdated registration assumptions.
6. Build ingredient disclosures from verified final-product data
Start with a controlled finished-product formula, vehicle information and fragrance-supplier disclosures. Calculate relevant allergens and restricted constituents, using the nomenclature and ingredient-order rules that apply in the destination market. Fragrance blend treatment, warning statements and flammability-related requirements may differ. Reformulation or supplier changes trigger renewed label and technical-file review even when artwork appears identical.
7. A market-by-market label approval gate
Use a jurisdiction matrix with columns for Egypt, EU and U.S. and rows covering classification, responsible party, ingredient list, allergens, warnings, lot traceability, claims, filings, supporting dossiers and source-verification date. Assign reviewers and status per market. Do not approve print artwork solely from a previous supplier list or assume IFRA paperwork satisfies every jurisdiction.
Case: a correct U.S. label may be incomplete in the EU
A U.S. cosmetics label includes the collective word 'Fragrance' for its mixture. The same artwork is copied for EU sale without checking named allergen declarations or the EU Responsible Person. Compliance in one market does not satisfy another. The correct workflow is a separate, traceable legal and technical review for each destination.
Practical exercise
Build a three-market checklist for a fictional body mist. List eight label and technical-dossier checkpoints, link each to a relevant authority and state what still needs confirmation. Explain why notification or registration is not a universal guarantee of safety or an approval of all claims.
Three illustrated concepts
Three-market comparison
- EU: responsible person and product dossier
- U.S.: labeling and applicable MoCRA
- Egypt: current national requirements
- Do not transplant jurisdictional approvals
EU ingredient declaration checks
- Ingredient names and grouped entries
- Leave-on disclosure trigger 0.001%
- Rinse-off disclosure trigger 0.01%
- 2026 placement / 2028 transition
Artwork approval checklist
- Intended use and legal entity
- Ingredients and warnings
- Batch traceability
- Safety and claims support
- Jurisdiction and review date
Technical glossary
- CPSR
- EU Cosmetic Product Safety Report.
- PIF
- EU Product Information File held by the Responsible Person.
- Placing on the market
- First making a product available in a market, distinct from later stock availability.
Official references and verification
Regulatory educational content based on the linked primary sources. Not legal advice, a safety approval or a substitute for checking current requirements.
